Could the AHCA Slow Interest in Genetic Testing?

While it remains uncertain what the Senate will do with the American Health Care Act (AHCA), alarm is spreading about the legislation's implications for the estimated quarter of Americans under the … [Read more...]


Medical Necessity Requirement Bites Anatomic Pathologists

By Robert Mazer  bio The DOJ has announced two separate settlements involving claims for allegedly unnecessary special stains. Medicare permits a pathologist to order special stains when … [Read more...]


FDA and Health Orgs Renew Focus on LDT Oversight

Late last year, the U.S. Food and Drug Administration (FDA) announced that it would not finalize the guidance on agency oversight of laboratory developed tests (LDTs) that it proposed back in 2014—at … [Read more...]


21st Century Cures Act Signed into Law

In a show of bipartisanship and further support of precision medicine and health care innovation—including genomics and other diagnostic innovations, the 21st Century Cures Act has become law. After … [Read more...]

Payment Reform Efforts to Support Cancer Care Coordination, Treatment Planning

The American Society of Clinical Oncology (ASCO) is proposing to profoundly reform payment for cancer care. ASCO's Patient-Centered Oncology Payment: Payment Reform to Support Higher Quality, More … [Read more...]

Congress Considering Reauthorization of Newborn Screening

Lawmakers have introduced legislation designed to help states with their newborn screening (NBS) programs. The Newborn Screening Saves Lives Reauthorization Act (H.R. 1281) was introduced in U.S. … [Read more...]

Sampling of Initiatives to Improve Price Transparency (goes with Inside the Diagnostics Industry article)

While early efforts to improve transparency in health care costs are targeting hospitals, expect the trend to continue to include laboratory test information as well. Federal The Department of … [Read more...]

Inside the Diagnostics Industry: Labs Facing Increasingly Cost-Conscious Consumers

Among the emerging trends that were discussed both in speakers’ presentations and among attendees at G2 Intelligence’s 31st annual Lab Institute “It’s Make or Break Time: A Path Forward for Labs” … [Read more...]